Side effects of Atorvastatin
- Myalgia
- Myopathy
- Muscle Weakness
- Muscle Spasm
- Headache
Proprotein Convertase Subtilisin/Kexin
Type – 9 (PCSK9) Inhibitors
ð PCSK9 is synthesised in
inactive form by many tissues, including brain and liver. It is activated
autocatalytically by proteolytic cleavage, which removes a section of
its peptide chain that blocks its activity.
ð When activated, it binds to LDL receptors and
promotes their lysosomal degradation (following LDL
uptake into hepatocyte cytoplasm), thereby
preventing recycling of LDL receptors to the surface membrane, and
diminishing their ability to sequester LDL.
The PCSK9 inhibitors binds with PCSK9 enzyme thereby inhibiting it to bind with the LDL receptor, so
that the lysosomal degradation of LDL
receptors not happens and the recycling of LDL receptors to the hepatocyte membrane occurs.
Comments
Post a Comment